通策医疗
(600763)
| 流通市值：218.37亿 | | | 总市值：218.37亿 |
| 流通股本：4.47亿 | | | 总股本：4.47亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 2,233,126,548.77 | 1,410,579,723.34 | 708,442,365.1 | 2,846,507,734.21 |
| 营业收入 | 2,233,126,548.77 | 1,410,579,723.34 | 708,442,365.1 | 2,846,507,734.21 |
| 二、营业总成本 | 1,606,451,888.31 | 1,033,135,038.13 | 492,607,244.78 | 2,199,965,580.72 |
| 营业成本 | 1,299,312,591.18 | 834,646,337.67 | 392,259,635.62 | 1,749,754,459.91 |
| 税金及附加 | 4,103,781.04 | 3,512,431.34 | 360,310.23 | 6,758,410.3 |
| 销售费用 | 25,708,384.75 | 13,985,464.77 | 6,720,315.24 | 29,311,186.69 |
| 管理费用 | 200,368,712.64 | 135,392,703.58 | 71,336,418.45 | 308,906,848.11 |
| 研发费用 | 41,050,496.48 | 22,956,198.63 | 11,235,139.47 | 55,645,592.78 |
| 财务费用 | 35,907,922.22 | 22,641,902.14 | 10,695,425.77 | 49,589,082.93 |
| 其中:利息费用 | 32,972,516.68 | 21,303,740.61 | 9,263,935.69 | 55,012,391.56 |
| 其中:利息收入 | 3,253,316.03 | 2,239,217.43 | 918,650.19 | 11,621,968.75 |
| 加:投资收益 | 37,386,765.97 | 24,689,597.9 | 12,329,246.39 | 60,192,880.13 |
| 资产处置收益 | 62,393.75 | - | - | - |
| 信用减值损失(新) | 1,487,698.86 | 1,577,981.75 | -1,850,168.62 | -3,921,291.43 |
| 其他收益 | 4,444,244.51 | 4,081,388.45 | 2,004,332.08 | 9,107,823.41 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 670,055,763.55 | 407,793,653.31 | 228,318,530.17 | 711,921,565.6 |
| 加:营业外收入 | 250,120.48 | 222,251.51 | 175,042.73 | 919,934.85 |
| 减:营业外支出 | 2,414,941.64 | 1,046,032.73 | 294,414.01 | 3,983,666.55 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 667,890,942.39 | 406,969,872.09 | 228,199,158.89 | 708,857,833.9 |
| 减:所得税费用 | 66,130,122.51 | 39,386,269.97 | 24,271,238.21 | 130,434,394.87 |
| 六、净利润 | 601,760,819.88 | 367,583,602.12 | 203,927,920.68 | 578,423,439.03 |
| 持续经营净利润 | 601,760,819.88 | 367,583,602.12 | 203,927,920.68 | 578,423,439.03 |
| 归属于母公司股东的净利润 | 498,270,940.75 | 309,811,977.84 | 173,215,140.31 | 500,474,706.63 |
| 少数股东损益 | 103,489,879.13 | 57,771,624.28 | 30,712,780.37 | 77,948,732.4 |
| (一)基本每股收益 | 1.11 | 0.97 | 0.54 | 1.56 |
| (二)稀释每股收益 | 1.11 | 0.97 | 0.54 | 1.56 |
| 八、其他综合收益 | -7,667,509.45 | -7,667,509.45 | 0.02 | -5,265,591.94 |
| 归属于母公司股东的其他综合收益 | -7,667,509.45 | -7,667,509.45 | 0.02 | -5,265,591.94 |
| 九、综合收益总额 | 594,093,310.43 | 359,916,092.67 | 203,927,920.7 | 573,157,847.09 |
| 归属于母公司股东的综合收益总额 | 490,603,431.3 | 302,144,468.39 | 173,215,140.33 | 495,209,114.69 |
| 归属于少数股东的综合收益总额 | 103,489,879.13 | 57,771,624.28 | 30,712,780.37 | 77,948,732.4 |
| 公告日期 | 2024-10-29 | 2024-08-24 | 2024-04-26 | 2024-04-26 |
| 审计意见(境内) | | | | 标准无保留意见 |